Data gathered: November 19
AI Stock Analysis - Sanofi (SNY)
Analysis generated July 14, 2024. Powered by Chat GPT.
Sanofi is a global biopharmaceutical company headquartered in Paris, France. Known for its extensive portfolio that includes pharmaceuticals, vaccines, and consumer healthcare products, Sanofi operates in over 100 countries. With a commitment to healthcare innovation, Sanofi invests heavily in research and development to drive growth and maintain its competitive edge in the pharmaceutical industry.
Stock Alerts - Sanofi (SNY)
 |
Sanofi | November 13 Web Traffic is up by 125% over the last month. |
|
Sanofi | October 23 Business Outlook among employees is up by 3.1% over the last month. |
|
Sanofi | October 18 Reddit mentions are up by 6200% in the last 24h. |
|
Sanofi | September 17 AI Score is up by 22.7% in the last couple of days. |
Alternative Data for Sanofi
About Sanofi
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.
| Price | $48.00 |
| Target Price | Sign up |
| Volume | 2,460,000 |
| Market Cap | $125B |
| Year Range | $43.57 - $58.53 |
| Dividend Yield | 4.25% |
| PE Ratio | 25.38 |
| Analyst Rating | 67% buy |
| Industry | Drug Manufacturers |
In the news
 |
Zacks Research Issues Positive Estimate for Sanofi EarningsNovember 18 - ETF Daily News |
 |
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for UrticariaNovember 18 - Yahoo |
 |
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin DiseaseNovember 15 - Biztoc.com |
 |
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticariaNovember 15 - Yahoo |
 |
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myelomaNovember 14 - Yahoo |
|
Crossmark Global Holdings Inc. Acquires 8,494 Shares of Sanofi (NASDAQ:SNY)November 13 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 14.2B | 4.09B | 10.1B | 2.82B | 4.25B | 1.570 |
| Q2 '24 | 11.4B | 6.85B | 4.53B | 1.11B | 2.03B | 0.930 |
| Q1 '24 | 11.1B | 3.44B | 7.68B | 1.13B | 2.87B | 0.970 |
| Q4 '23 | 22.9B | 9.06B | 13.8B | 1.97B | 1.64B | 0.890 |
| Q3 '23 | 12.7B | 3.84B | 8.86B | 2.53B | 3.92B | 2.770 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$153 1.1% | 51 |
 |
Eli Lilly and CompanyLLY |
$729.73 0.3% | 63 |
 |
PfizerPFE |
$25.1 1% | 48 |
 |
AstrazenecaAZN |
$63.8 0.6% | 69 |
 |
AbbVieABBV |
$166.57 0.2% | 54 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Sanofi (SNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Sanofi?
The Market Cap of Sanofi is $125B.
What is Sanofi's PE Ratio?
As of today, Sanofi's PE (Price to Earnings) ratio is 25.38.
What is the current stock price of Sanofi?
Currently, the price of one share of Sanofi stock is $48.00.
How can I analyze the SNY stock price chart for investment decisions?
The SNY stock price chart above provides a comprehensive visual representation of Sanofi's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sanofi shares. Our platform offers an up-to-date SNY stock price chart, along with technical data analysis and alternative data insights.
Does SNY offer dividends to its shareholders?
Yes, Sanofi (SNY) offers dividends to its shareholders, with a dividend yield of 4.25%. This dividend yield represents Sanofi's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Sanofi in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Sanofi?
Some of the similar stocks of Sanofi are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.